Terence Flynn

Stock Analyst at Morgan Stanley

(3.98)
# 558
Out of 4,851 analysts
192
Total ratings
56.44%
Success rate
8.38%
Average return

Stocks Rated by Terence Flynn

Arvinas
May 9, 2025
Maintains: Equal-Weight
Price Target: $12$11
Current: $6.95
Upside: +58.27%
Arcus Biosciences
May 9, 2025
Maintains: Overweight
Price Target: $24$22
Current: $9.60
Upside: +129.17%
BioNTech SE
May 6, 2025
Maintains: Overweight
Price Target: $140$132
Current: $111.15
Upside: +18.76%
Organon & Co.
May 5, 2025
Maintains: Equal-Weight
Price Target: $15$10
Current: $9.53
Upside: +4.93%
United Therapeutics
May 1, 2025
Maintains: Equal-Weight
Price Target: $346$348
Current: $323.97
Upside: +7.42%
AbbVie
Apr 28, 2025
Maintains: Overweight
Price Target: $241$250
Current: $187.34
Upside: +33.45%
Johnson & Johnson
Apr 16, 2025
Maintains: Equal-Weight
Price Target: $164$169
Current: $153.22
Upside: +10.30%
Eli Lilly and Company
Apr 9, 2025
Maintains: Overweight
Price Target: $1,146$1,124
Current: $765.84
Upside: +46.77%
Amgen
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $328$330
Current: $287.01
Upside: +14.98%
Biohaven
Mar 7, 2025
Maintains: Overweight
Price Target: $69$63
Current: $16.21
Upside: +288.65%
Maintains: Underweight
Price Target: $30$32
Current: $38.05
Upside: -15.90%
Maintains: Equal-Weight
Price Target: $113$106
Current: $78.27
Upside: +35.43%
Maintains: Equal-Weight
Price Target: $16$17
Current: $12.19
Upside: +39.52%
Downgrades: Equal-Weight
Price Target: $56$11
Current: $7.67
Upside: +43.42%
Maintains: Underweight
Price Target: $36$39
Current: $47.95
Upside: -18.67%
Maintains: Equal-Weight
Price Target: $30$31
Current: $23.39
Upside: +32.54%
Initiates: Overweight
Price Target: $118
Current: $22.00
Upside: +436.36%
Initiates: Overweight
Price Target: $36
Current: $3.41
Upside: +955.72%
Maintains: Overweight
Price Target: $48$51
Current: $33.44
Upside: +52.51%
Maintains: Buy
Price Target: $121$168
Current: $128.10
Upside: +31.15%
Maintains: Equal-Weight
Price Target: $1$8
Current: $1.54
Upside: +419.48%
Maintains: Neutral
Price Target: $246$436
Current: $131.86
Upside: +230.65%
Upgrades: Buy
Price Target: n/a
Current: $305.31
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $0.31
Upside: -